Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Sanofi    SAN   FR0000120578

SANOFI (SAN)

Real-time Quote. Real-time Tradegate - 07/28 10:03:33 pm
76.786 EUR   +0.11%
09:07p SANOFI : Merial to merge with Boehringer Ingelheim
05:21p SANOFI : Canada’s Next Generation of Bioscientists
07:28aDJSANOFI : US FDA Approves Sanofi's Adlyxin to Help Treat Type 2 Diabe..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

SANOFI : Former Sanofi employees convicted of bribery in Germany

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/03/2014 | 07:24pm CEST

A German court convicted two former employees of Sanofi-Aventis on bribery charges 10 months ago and imposed a fine on the French drugmaker last year, prosecutors said on Monday following a newspaper report.

News of the 28 million euro ($39 million) fine coincides with heightened scrutiny of Big Pharma's sales practices after a bribery scandal in China hit business there last year.

Further investigations are ongoing, a spokesman for prosecutors in the northern German town of Verden said, confirming a report by German daily newspaper Frankfurter Allgemeine Zeitung, but they declined to say whether these were related to Sanofi or to its employees.

The spokesman said an investigation of the former Sanofi employees found that they had made illicit payments to a consultancy advising one of the drugmaker's clients between 2007 and 2010 to win more orders from the client, a pharmaceuticals dealer.

"Sanofi was unfairly given preference because of this," he said.

He declined to provide details on who the client was or which markets it operated in. He also did not name the former Sanofi employees or the consultant.

A court in the town of Winsen handed the two former employees of Sanofi suspended sentences for bribery in business transactions in May 2013, the spokesman said. They both worked with Sanofi's sales force and were not senior managers.

The Winsen court also ordered that punishment be meted out to the owner of the consultancy, but that judgment was not yet final due to a pending complaint against the ruling.

The bribery investigation has not come to light until now because the suspects were sentenced via a simplified legal process that under German law allows courts to try some crimes without a courtroom trial.

The court's ruling also resulted in a 28 million euro fine for Sanofi. A spokeswoman for Sanofi-Aventis Deutschland GmbH confirmed the company had to pay that sum in connection with the case against the two former employees.

"For Sanofi the matter is closed," the spokeswoman said, referring to the Winsen court's rulings. She added the company had cooperated with authorities during the investigation and had since further tightened its compliance system.

Sanofi acquired Aventis in 2004, creating Sanofi-Aventis. In 2011, the company simplified its name to Sanofi.

(Reporting by Maria Sheahan and Frank Siebelt; Additional reporting by Natalie Huet in Paris; Writing by Marilyn Gerlach; editing by Mike Collett-White)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on SANOFI
09:07p SANOFI : Merial to merge with Boehringer Ingelheim
05:21p SANOFI : Canada’s Next Generation of Bioscientists
07:28aDJSANOFI : US FDA Approves Sanofi's Adlyxin to Help Treat Type 2 Diabetes
01:46a SANOFI : ​Sanofi Receives FDA Approval of AdlyxinTM for Treatment of Adult..
01:45a SANOFI : Receives FDA Approval of AdlyxinTM for Treatment of Adults with Type 2 ..
07/27DJRenault Board Cuts CEO's 2016 Pay After Spat With Shareholders
07/27DJSANOFI : 2Q 2016 -- Forecast
07/26 SANOFI : India ends in green; SC refuses early hearing
07/26 Exclusive - Teva, Mylan eye Pfizer's Brazil venture, sources say
07/26SANOFI SA : half-yearly earnings release
More news
Sector news : Pharmaceuticals - NEC
07:12pDJBRISTOL MYERS SQUIBB : -Myers Results Boosted by Cancer Drugs -- Update
03:28pDJU.S. HOT STOCKS : Hot Stocks to Watch
01:42pDJALEXION PHARMACEUTICALS : Cuts Profit Guidance
01:35pDJBRISTOL MYERS SQUIBB : -Myers Results Boosted by Cancer Drugs
01:16pDJBRISTOL MYERS SQUIBB : -Myers Results Boosted by Cancer Drugs
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
11:32a Roche's hemophilia candidate emicizumab shows encouraging results in early-st..
10:23a FDA OKs Sanofi's lixisenatide for type 2 diabetes
07/27 MANNKIND : Beware Of Dog
07/27 MY EARNINGS GAME PLAN : July 28-29
07/25 Is Biotech Finally Ready To Move Higher?
Advertisement
Financials (€)
Sales 2016 37 154 M
EBIT 2016 9 370 M
Net income 2016 5 093 M
Debt 2016 5 594 M
Yield 2016 3,91%
P/E ratio 2016 17,79
P/E ratio 2017 16,17
EV / Sales 2016 2,81x
EV / Sales 2017 2,76x
Capitalization 98 859 M
More Financials
Chart SANOFI
Duration : Period :
Sanofi Technical Analysis Chart | SAN | FR0000120578 | 4-Traders
Full-screen chart
Technical analysis trends SANOFI
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 85,0 €
Spread / Average Target 11%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Olivier Brandicourt Chief Executive Officer & Director
Serge Weinberg Chairman
JÚr˘me Contamine Chief Financial Officer & EVP-Finance
Elias E. Zerhouni President-Global Research & Development
Yong-Jun Liu Head-Global Research & Development
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
SANOFI-2.42%109 416
JOHNSON & JOHNSON21.47%343 198
PFIZER INC.14.16%223 490
ROCHE HOLDING LTD.-9.99%216 972
NOVARTIS AG-5.30%216 918
MERCK & CO., INC.10.94%162 206
More Results